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Abstract
Purpose Ventral hernia repair is one of the most frequently performed surgical procedures, though recurrences are common. 
Recurrence can be caused by impaired collagen formation or maturation; hence, patients with Ehlers-Danlos syndrome (EDS) 
are potentially at increased risk for hernia recurrence. EDS causes altered collagen metabolism, though little is known about 
the influence of EDS on ventral hernioplasty outcomes. This study aims to analyze these patients to report complication 
rates, recurrence rates, and, if possible, to give recommendations for surgical intervention.
Methods A retrospective analysis between January 2000 and January 2017 was performed in a university hospital Belgium 
(UZ Ghent). Data on baseline characteristics, primary surgery, and hernias were extracted from patients’ medical charts. 
Noted endpoints were postoperative complications and recurrences.
Results Fourteen patients (50% males) were included. Ten (71%) had an incisional hernia and four (29%) had a primary 
ventral hernia. Median age was 45 years (IQR 37.75–52.75), median BMI was 24.82 (IQR 22.43–26.87). Four patients 
(29%) smoked, one patient (7.1%) had diabetes mellitus, and five patients (36%) had an aneurysm of the abdominal aorta. 
All patients underwent elective open hernioplasty with mesh reinforcement. Three patients (21%) had a postoperative com-
plication (two infections, one seroma). Recurrence rate was 7.1% (one patient).
Conclusions This series describes 14 patients with a median follow-up of 50 months and a recurrence rate of 7.1%. The low 
recurrence rate could be explained by the use of large meshes that reinforce the entire midline to compensate for the reduced 
collagen strength in EDS patients.
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Introduction
Incisional hernia formation is one of the most frequent com-
plications after abdominal surgery with midline laparotomy, 
occurring in 11–20% of all laparotomies in the general popu-
lation [1]. When patients have risk factors (obesity, smoking 
or abdominal aortic aneurysm), this rate can increase up to 
35% [2].
It is hypothesized that a disturbed balance between mature 
and immature collagen can be part of the underlying mecha-
nism leading to incisional hernia formation. Klinge et al. 
explain recurrent hernia formation as a combined problem of 
biology and technique [3]. The human extracellular matrix 
consists of twenty different types of collagen, of which 95% 
is type I and III collagen [4]. Patients with recurrent ventral 
hernias have a decreased collagen I/III ratio. Collagen type 
I is mature, mechanically stable collagen, whereas collagen 
type III is immature, mechanically instable collagen [3]. 
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Alongside the previously mentioned collagens, it has been 
hypothesized by Schumpelick et al. that tenascin, a family 
of glycoproteins, could be linked to hernia formation [5]. 
Given this mechanism, patients with an underlying connec-
tive tissue disease, such as Ehlers-Danlos syndrome (EDS), 
can be at risk for a higher recurrence rate after both ventral 
and incisional hernia repair [5–7]. EDS was first described in 
1901 and the syndrome characterizes itself by a triad of skin 
hyperextensibility, joint hypermobility, and tissue fragility. 
Originally, EDS was divided into numbered subtypes. In 
1998, the Villefranche classification scheme divided EDS 
into six subtypes, based on clinical features, biochemical 
and genetic findings, and mechanism of inherence: classic 
(type I and II), hypermobility (type III), vascular (type IV), 
kyphoscoliosis (type VI), arthrochalasia (type VIIA and 
VIIB), and dermatosparaxis (type VIIC) [8, 9]. Because of 
overlapping symptoms in these different subtypes, categoriz-
ing EDS is no easy task. Including all subtypes of EDS, the 
incidence is approximately one in 5000 people, of which the 
hypermobility subtype is most common [8].
The recently published international classification of the 
Ehlers-Danlos Syndrome describes the genetic basis for 
each type of EDS. The classical, vascular, and arthrochalasia 
types have been linked to either type I or type III collagen 
disorders [4, 10]. The hypermobility type is linked to tenas-
cin X alterations. Although not all types of EDS have been 
linked to a specific protein disorder, many surgeons fear a 
high recurrence rate following hernia repair in EDS patients 
because of similar collagen disorders associated with both 
EDS and hernia recurrence [5–7].
EDS can potentially influence every part of the body 
where connective tissue is present. The literature on the 
relationship between EDS and hernia development is scarce 
and only includes a few case reports. Despite the lack of 
evidence, many surgeons believe that EDS may have a nega-
tive effect on the clinical outcome of ventral hernioplasty 
in terms of both higher postoperative complication and 
recurrence rates. The aim of this retrospective case series 
is to evaluate outcomes of ventral hernioplasty in patients 
with Ehlers-Danlos syndrome, the primary outcome is her-
nia recurrence and the secondary outcome is postoperative 
complications.
Methods
A retrospective analysis of hospital registries between Janu-
ary 2000 and January 2017 was performed in a large univer-
sity hospital in Ghent, Belgium (Ghent University Hospital). 
Before commencement of the study, ethical approval and 
approval of the Institutional Review Boards was obtained. 
The hospital central registry was searched using either 
ICD-10/ICD-9-CM or Diagnosis Treatment Codes (DBC) 
for collagen disorder (Q79.6/756.83) and ‘hernioplasty’ 
(0303.123/0303.124). Any patient with a history of EDS 
(any type) and a ventral abdominal hernioplasty was eligible 
for inclusion in this study. Patients who registered an objec-
tion for participation in scientific research in their medical 
chart were excluded. Follow-up was obtained from patients’ 
medical charts. All EDS patients were seen 3 weeks postop-
eratively, as well as every 6 months hereafter.
Data collection
The following data were extracted from patients medical 
charts: baseline characteristics (age, sex, body mass index 
(BMI), smoking, medical history and type of Ehlers-Dan-
los), information about the hernia (date of diagnosis, type of 
hernia, size, primary/recurrent hernia, complaints), details 
regarding the surgical procedure (date of operation, elec-
tive/emergency procedure, type of procedure, mesh type and 
size and drain placement), postoperative data (postoperative 
complications (seroma, hematoma, surgical site infection, 
other infection, mesh explantation, and recurrence)), and 
follow-up (duration, number of outpatient clinic visits, read-
missions, reoperations, and complaints). Hernia characteris-
tics were reported using the European Hernia Classification 
of the European Hernia Society (EHS) [11]. All data were 
stored and analyzed in  SPSS® for windows version 24, IBM 
corp. Armonk, NY, released 2013.
Results
A total of 14 patients (seven males, seven females), with a 
median age of 45 years (range 24–60 years) were included 
with diagnosis dates between June 2009 and July 2016. 
Median BMI was 24.82 (IQR 22.43–26.87). Four patients 
smoked (29%), one patient (7.1%) had diabetes mellitus, and 
five patients (36%) had an aneurysm of the abdominal aorta. 
Ten patients (71%) were ASA Class II and three patients 
(21%) were ASA Class III.
Two patients (7.1%) had the classic type Ehlers-Danlos, 
six patients (43%) had the hypermobility type, and four 
patients (29%) had the vascular type. Patient baseline char-
acteristics are shown in Table 1.
Hernia characteristics
Ten patients (71%) had an incisional hernia and four patients 
(29%) had a primary hernia (see Fig. 1 for hernia character-
istics). One of the incisional hernias was a recurrent hernia, 
previously treated with a  Marlex® mesh. The median hernia 
length of the primary hernias was 2.5 cm (range 2.0–5.0 cm), 
and the median width was 2.0 cm (range 1.5–3.0 cm). The 
median hernia length of the incisional hernias was 5.0 cm 
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(range 0.6–25 cm), and the median width was 3.5 cm (range 
0.8–15 cm). None of the patients underwent any concomi-
tant procedures, nor had they concomitant hernias in other 
locations.
Surgical characteristics
All hernia repair procedures were elective (see Table 2 
for operation details). In all patients, open surgery was 
performed, one procedure (a recurrent hernia repair) was 
planned as a laparoscopic procedure, but converted into an 
open procedure because of severe adhesions in the abdomi-
nal cavity. All patients received mesh reinforcement in 
either onlay (n = 1, 7%), sublay (n = 9, 64%), preperitoneal 
(n = 3, 21%), or intraperitoneal (n = 1, 7%) position. The 
onlay procedure was performed using an  Adhesix® mesh, 
sublay repairs were performed with  UltraPro® (n = 7), 
 Adhesix® (n = 1), or  Rebound® (n = 1) mesh. Preperitoneal 
repairs were performed using the  Ultrapro® (n = 1, 33%), or 
 Rebound® (n = 2, 67%) mesh, and the intraperitoneal proce-
dure was performed using a  Dualmesh®. Average mesh size 
was 399 cm2 (range 63–900 cm2), with an average length 
of 23 cm (range 7.0–35 cm), and width of 16 cm (range 
8.0–30 cm). All sublay repairs could be closed in the midline 
using the Rives-Stoppa technique without the need for addi-
tional procedures (component separation or other). Eleven 
patients (79%) received a drain at the end of the procedure.
Perioperative outcomes
No intra-operative complications were recorded. Postop-
erative complications occurred in three patients (21%) 
Table 1  Patient characteristics
IQR interquartile range, BMI body mass index, ASA American Soci-
ety of Anesthesiologists
Patient characteristics N = 14
Age at operation, years (IQR) 45 (38–53)
Male (%) 7 (50)
BMI, kg/m2 (IQR) 24.82 (22.43–26.87)
Smoking (%) 4 (29)
Diabetes mellitus (%) 1 (7.1)
Abdominal aortic aneurysm (%) 5 (36)
ASA Class (%)
 I 0 (0)
 II 10 (71)
 III 3 (21)
 IV 0 (0)
 Unknown (%) 1 (7.1)
Ehlers-Danlos type (%)
 Classic (type I and II) 2 (7.1)
 Hypermobility (type III) 6 (43)
 Vascular (type IV) 4 (29)
 Kyphoscoliosis (type VI) 0 (0)
 Arthrochalasia (type VIIA and B) 0 (0)
 Dermatosparaxis (type VIIC) 0 (0)
 Unknown (%) 2 (14)
Type of primary surgery (in case of incisional hernia, n = 10)
 Gynecologic 2
 Vascular 4
 Gastric 3
 Colorectal 1
Fig. 1  Hernia characteristics. Hernia characteristics of all included 
patients. Characteristics are reported according to the European Her-
nia Society (EHS) guidelines for hernia classification. Width for inci-
sional hernias (W1 = < 4 cm; W2 ≥ 4–10 cm; W3 ≥ 10 cm), width 
for primary hernias (W1 < 2 cm; W2 ≥ 2–4 cm; W3 ≥ 4 cm)
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(Table 3). Mean hospital stay was 3.4 days (± 1.04 days). 
One patient (7%) had a seroma and two patients (14%) had 
a surgical site infection. One of the patients with a surgical 
site infection had a BMI of 30.4 kg/m2; the other patient had 
a relatively large hernia (25 × 15 cm). One of the patients 
with a surgical site infection required antibiotic treatment 
and was, therefore, classified as a Clavien-Dindo Grade II 
complication [12]. The remaining two complications were 
Grade I. No other complications were recorded in the 30-day 
postoperative period.
Long‑term outcomes
Median follow-up after surgery was 50 months (IQR 18–82, 
range 6–152 months). Patients visited the outpatient clinic a 
mean of three times (range 1–4 times). During this follow-up 
period, recurrences were assessed using clinical examina-
tion (n = 3, 29%), or clinical examination combined with 
ultrasonography (n = 10, 71%). One patient (7%) developed 
a hernia recurrence diagnosed by clinical examination. This 
patient was a 37-year-old female with EDS type III without 
relevant comorbidity or medical history (no diabetes, no aor-
tic aneurysm, no smoking). The patient’s BMI was 25.7. She 
presented with a primary umbilical hernia of 2 × 2 cm (EHS 
Primary Abdominal wall Hernia Class: Midline Epigastric 
Medium hernia). She underwent an elective open repair 
with a preperitoneal mesh placement  (Rebound® 9 × 8 cm) 
in August 2009. The procedure was without any complica-
tion. She developed a clinical recurrence after approximately 
24-month follow-up, which resulted in esthetic complaints. 
The patient did not seek medical attention for her recurrence 
until 89-month follow-up, as she does not wish to undergo 
reoperation for the recurrence. No readmissions were per-
formed. During follow-up, one patient died due to brain 
hemorrhage, unrelated to the hernioplasty procedure. For 
this patient, no long-term follow-up was available.
Discussion
This case series of 14 patients with Ehlers-Danlos syndrome 
(EDS) undergoing ventral hernia repair shows a 7.1% recur-
rence rate after a median follow-up period of 50 months. 
Current literature on ventral hernioplasty in EDS patients 
is scarce with only a hand full of case reports. Girotto et al. 
describes two patients with EDS and recurrent ventral 
abdominal wall hernias [13]. He treated these patients with 
a components separation technique and an onlay  Marlex® 
mesh. Follow-up in this study is not described clearly. Fogel 
et al. describes a series of six ventral hernia repairs, of 
which two patients got a recurrent hernia, though important 
details regarding the surgical procedure and follow-up are 
not described as the focus of the article is on EDS and not 
on ventral hernia repair.
The current series is the first study that looks at patients 
with EDS as a specific risk group for developing hernia 
recurrence. Even though the detailed pathophysiology of 
incisional hernia formation is still illusive, many factors 
influence surgical wound healing and ultimately hernia for-
mation [14]. One important factor is collagen synthesis and 
maturation. Given the well-established collagen impairment 
in EDS patients, a high recurrence rate in this population 
was anticipated. However, the 7% recurrence rate after open 
mesh repair in this study is lower than the 12% found in lit-
erature in the general patient population after elective open 
ventral hernioplasty with mesh reinforcement, after a median 
follow-up of 59 months [15]. The low recurrence rate can 
potentially be explained by the large mesh size. The average 
Table 2  Surgical characteristics
SD standard deviation
a One procedure started as a laparoscopic procedure, but was con-
verted into an open procedure
Characteristic N = 14
Open procedure (%) 14a (100)
Emergency (%) 0 (0)
Mesh location (%)
 Onlay 1 (7.1)
 Sublay/retromuscular 9 (64)
 Preperitoneal 3 (21)
 Intraperitoneal 1 (7.1)
Mesh type (%)
 Ultrapro 8 (57)
 Dualmesh 1 (7.1)
 Adhesix 2 (14)
 Rebound 3 (21)
Mesh size
 Length, cm (range) 22.9 (7.2–35)
 Width, cm (range) 15.8 (8–30)
 Surface (length × width),  cm2 (range) 399 (63–900)
Drain placement (%) 11 (79)
Length of hospital stay, days (SD) 3.38 (1.04)
Table 3  Perioperative complications
Complication N = 14
No complications (%) 11 (79)
Seroma (%) 1 (7.1)
Hematoma (%) 0 (0)
Surgical site infection (%) 2 (14)
Other infection (%) 0 (0)
Mesh explantation (%) 0 (0)
Other (%) 0 (0)
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mesh size in this series was 16 × 23 cm, for an average 
hernia size of 3 × 5 cm. The ‘oversized’ mesh ensured a 
large surface for tissue ingrowth, which could compensate 
for the reduced collagen quality. Additionally, all patients 
were known to be diagnosed with EDS preoperatively. This 
might lead to a higher awareness of the surgeon. More con-
servative choices could have been made and more attention 
to the suturing technique could have been given. These fac-
tors, however, are hard to objectify.
During the 17-year inclusion period of this consecu-
tive case series, only 14 patients were identified. There are 
several explanations for the relatively low number of EDS 
patients with ventral hernias. The most obvious one would 
be the low prevalence of EDS (1:5000). Another, more trou-
bling, explanation would be identification failure of EDS in 
the outpatient hernia clinic. Since this case series is one of 
the first articles to discuss the potential influence of EDS on 
ventral hernia surgery outcomes, the problem may be under-
estimated or overlooked. Since EDS may be ‘diagnosed’ by 
one of many physicians either inside, or outside the hospi-
tal, central hospital registries may not always be up-to-date 
concerning the patient history. Hence, the treating physician 
must actively acquire information regarding EDS symptoms 
to not overlook the disease in the outpatient hernia clinic.
Limitations
A retrospective case series is methodologically unsuit-
able to determine the recurrence rate of ventral hernias in 
EDS patients accurately; hence, the percentages reported in 
this series must be interpreted with caution. Furthermore, 
because of the small sample size, detailed analysis of the 
relations between different types of EDS and clinical out-
comes could not be made. Additionally, only two of the four-
teen patients (14%) had the classic EDS type. Although no 
in-depth analyses exist on the different subtypes of EDS and 
hernia recurrence, it could be hypothesized that the classic 
type would be more prone to recurrence than other types. 
This could partially explain the relatively low recurrence 
rate found in this study.
Finally, some patients had a relatively short follow-up 
period. This could potentially lead to an underreported 
recurrence rate.
Despite the abovementioned limitation, it is the authors’ 
opinion that the following conclusions can be made based 
on the results of this article.
Recommendations for hernioplasty in EDS patients
• Establishing the diagnosis Ehlers-Danlos syndrome 
is the first step in providing tailored care for this com-
plex patient population. If the family history or physical 
examination suggests Ehlers-Danlos syndrome, further 
examination is advised before attempting ventral abdomi-
nal wall hernioplasty.
• Treat ‘small’ ventral abdominal wall hernias as if they 
were bigger. The patients described in this series pre-
sented with relatively ‘small’ ventral hernias, though they 
were treated with a large (oversized) mesh and an exten-
sive repair (most often Rives-Stoppa) with reinforcement 
along the entire midline or previous incision. Using large 
meshes provides a large surface for tissue ingrowth, 
which could compensate for the collagen impairment in 
EDS patients.
Conclusion
Patients with EDS are prevalent in the ventral abdominal 
wall hernia population. Identifying these patients is the first 
step towards tailored care. This series describes 14 patients 
with a median follow-up of 50 months and a recurrence rate 
of 7.1% (one patient). The low recurrence rate observed in 
this series might be explained by the use of a large mesh and 
reinforcement of the entire midline to compensate for the 
reduced collagen strength in EDS.
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